India · Delayed Price · Currency is INR Suven Life Sciences Statistics
Total Valuation
BOM:530239 has a market cap or net worth of INR 98.21 billion. The enterprise value is 93.20 billion.
| Market Cap | 98.21B |
| Enterprise Value | 93.20B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:530239 has 263.72 million shares outstanding. The number of shares has increased by 9.53% in one year.
| Current Share Class | 263.72M |
| Shares Outstanding | 263.72M |
| Shares Change (YoY) | +9.53% |
| Shares Change (QoQ) | +16.81% |
| Owned by Insiders (%) | 1.88% |
| Owned by Institutions (%) | 2.93% |
| Float | 75.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,114.27 |
| PB Ratio | 16.61 |
| P/TBV Ratio | 16.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -587.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -413.71% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.66% |
| Revenue Per Employee | 620,690 |
| Profits Per Employee | -24.82M |
| Employee Count | 142 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.37% in the last 52 weeks. The beta is 0.80, so BOM:530239's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +58.37% |
| 50-Day Moving Average | 313.13 |
| 200-Day Moving Average | 212.98 |
| Relative Strength Index (RSI) | 65.15 |
| Average Volume (20 Days) | 72,346 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:530239 had revenue of INR 88.14 million and -3.52 billion in losses. Loss per share was -14.74.
| Revenue | 88.14M |
| Gross Profit | 81.82M |
| Operating Income | -3.72B |
| Pretax Income | -3.52B |
| Net Income | -3.52B |
| EBITDA | -3.67B |
| EBIT | -3.72B |
| Loss Per Share | -14.74 |
Balance Sheet
The company has 5.18 billion in cash and 166.94 million in debt, with a net cash position of 5.01 billion or 19.01 per share.
| Cash & Cash Equivalents | 5.18B |
| Total Debt | 166.94M |
| Net Cash | 5.01B |
| Net Cash Per Share | 19.01 |
| Equity (Book Value) | 5.91B |
| Book Value Per Share | 22.43 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -3.01 billion and capital expenditures -50.83 million, giving a free cash flow of -3.06 billion.
| Operating Cash Flow | -3.01B |
| Capital Expenditures | -50.83M |
| Depreciation & Amortization | 51.88M |
| Net Borrowing | -3.73M |
| Free Cash Flow | -3.06B |
| FCF Per Share | -11.62 |
Margins
| Gross Margin | 92.83% |
| Operating Margin | -4,223.81% |
| Pretax Margin | -3,998.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:530239 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.53% |
| Shareholder Yield | -9.53% |
| Earnings Yield | -3.59% |
| FCF Yield | -3.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 23, 2007. It was a forward split with a ratio of 4.
| Last Split Date | Mar 23, 2007 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |